3Pagano G, Paeini G, Musso G, et al. Non-alcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for anetiologic as sociation[J]. Hepatology, 2002,35 (7) : 367-372.
4Sookoian S,Pirola CJ.Non-alcoholic fatty liver disease is strongly associated with carotid atheroscoerosis: a systematic review [J]. J Hepatol, 2008,49 : 600-607.
5Depronzo R A.Insuoin resistance, lipotoxicity, type 2 diabetes and atheroselerosis:the missing links The Claude Bernard Lecture 2009[J]. Diabetologia,2010,53(7) :1270-1287.
6Czyzewska M. Disturbances of lipoprotein metabolism in metabolic syndrome [J]. Postepy Hig Med Dosw(online), 2010,64 : 1-10.
7Gouni- Berthold I,Sachinidis A.Possible non-classic intracellular and molecular mechanism of LDL cholesterol action contributing to the development and progression ofatheroselerosis [J]. Curr vase Pharmacol, 2004,2(4) :363-370.
5Marchesini G,Brizi M,Bianchi G,et al.Nonalcoholic fatty liver disease:A feature of the metabolic syndrome.Diabetes,2001,50:1844-1850.
6Vozarova B,Stefan N,Lindsay RS,et al.High alanine aminotransferase is associated with decrease hepatic insulin sensitivity and predicts the development of type 2 diabetes.Diabetes,2002,51:1189-1895.
7Nakanishi N,Suzuki K,Tatara K.Serum γ-glutamyltransferase and risk of metabolic syndrome and type 2 diabetes in middleaged Japanese men.Diabetes Care,2004,27:1427-1432.
8Nannipieri M,Gonzales C,Baldi S,et al.Liver enzymes,the metabolic syndrome and incident diabetes:The mexico city diabetes study.Diabetes Care,2005,28:1757-1762.
9Hanley AJ,Williams K,Festa A,et al.Elevations in markers of liver injury and risk of type 2 diabetes the insulin resistance atherosclerosis study.Diabetes,2004,53:2623-2632.
